Does EPIRUBICIN Cause Second primary malignancy? 155 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 155 reports of Second primary malignancy have been filed in association with EPIRUBICIN (Ellence). This represents 1.0% of all adverse event reports for EPIRUBICIN.
155
Reports of Second primary malignancy with EPIRUBICIN
1.0%
of all EPIRUBICIN reports
38
Deaths
44
Hospitalizations
How Dangerous Is Second primary malignancy From EPIRUBICIN?
Of the 155 reports, 38 (24.5%) resulted in death, 44 (28.4%) required hospitalization, and 15 (9.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPIRUBICIN. However, 155 reports have been filed with the FAERS database.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Myelosuppression (934)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which EPIRUBICIN Alternatives Have Lower Second primary malignancy Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL